Is the problem urgent enough?
Your deck showsWho has the problem, what it costs and how many there are.
Biotech Pitch Deck Support for Fundraising
Biond supports biotech founders with the investor narrative, slide structure, writing and design for a live raise. You get a deck investors understand in one read, built on evidence you can back up.
For biotech and life science startups raising seed to Series B, from therapeutics and diagnostics to ag-biotech and food tech.
· What investors check
Six questions every biotech investor deck has to answer
Investors look for these answers in the first few minutes. We build your narrative around them, using only claims your data supports.
Why does this win over what exists?
Your deck showsA head-to-head with current approaches, on what buyers measure.
What is proven, and what is next?
Your deck showsYour strongest data, and the milestones this round reaches.
Can these people deliver it?
Your deck showsThe experience the plan needs, and the hires still to make.
What does the money buy?
Your deck showsA budget tied to milestones, and the runway it gives you.
How much, and why now?
Your deck showsThe round size, who is already in, and the value inflection it funds.
· What you get
What biotech pitch deck support includes
Narrative, writing and design in one project. Take all three, or only what your current deck is missing.
Investor narrative
We review your science, data and plan, then agree the one story the deck has to tell.
OutputNarrative outline on one page
Structure and writing
One message per slide, headlines that state the point, and the detail moved to an appendix for due diligence.
OutputSlide by slide copy and speaker notes
Design
A clean template, data charts and science figures that explain at a glance.
OutputEditable deck and a PDF to send
· Before and after
One slide, rewritten for investors
The same ag-biotech data, twice. Nothing is removed or inflated. The order and emphasis change.
Illustrative example
Before: written for scientists
- The headline describes a method, not a result
- Five data points carry equal weight
- The best result for investors sits in the last line
After: written for investors
- The headline states the result, and evidence follows
- Mechanism moves to the appendix for due diligence
- The slide ends on what this round pays for
· Results
What changes when your deck is clear
A deck often gets read before you are in the room. It has to make the case on its own.
- Investors understand the opportunity in one read, without you there to explain it
- First meetings go to the business case and the round, not to the mechanism
- Every claim traces to data you can show in due diligence
We never inflate market size, projections or results. If a claim needs more evidence, you hear it from us before an investor asks.
· Who it's for
Biotech pitch deck support is for you if
- You are raising seed to Series B and your deck still reads like a conference talk.
- Investors ask you to explain the science again on every call.
- Your raise has a date and the deck has to be ready before it.
· Use it next
Related services
· Contact
Tell us where you're stuck.
One conversation. You leave with a clearer next step, whether or not we work together.
We only use your details to reply. Privacy policy
· FAQ
Biotech pitch deck questions
Investor narrative, slide structure, writing and design for a live raise. You can take the full package, or only the parts your current deck is missing, such as a new story on top of a design you already like.
Biotech and life science startups raising seed to Series B: therapeutics, diagnostics, medtech and platform companies, plus ag-biotech, food tech and cultivated protein companies. That last group often pitches to generalist investors, so the science has to be clear without a specialist in the room.
We structure and present the market sizing and projections you have, and flag the assumptions investors are likely to challenge. The figures come from your data and your financial model. We don't invent or inflate them.
Most decks take a few weeks, depending on how settled the story is and how quickly reviews move. If your raise has a date, we plan backwards from it. A short scoping call gives you a firm timeline.
An editable deck in PowerPoint or Google Slides, plus a PDF to send ahead of meetings. You own every file.
If you can't yet say in one sentence why your science wins, yes. Positioning and messaging gives the deck its story, and the deck goes faster for it.
Yes. We are based in Singapore and work remotely with companies across Southeast Asia and Europe.